• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: Persistent endeavors for the enhancement of dissolution and oral bioavailability.

作者信息

Wu Wei, Lu Yi, Qi Jianping

机构信息

Key Laboratory of Smart Drug Delivery of MOE and PLA, School of Pharmacy, Fudan University, Shanghai 201203, China.

出版信息

Acta Pharm Sin B. 2019 Jan;9(1):2-3. doi: 10.1016/j.apsb.2019.01.009. Epub 2019 Jan 29.

DOI:10.1016/j.apsb.2019.01.009
PMID:30766773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6361848/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a1/6361848/a2a006e49fd2/fx3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a1/6361848/94e4d3bd8910/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a1/6361848/cedc8237944a/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a1/6361848/a2a006e49fd2/fx3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a1/6361848/94e4d3bd8910/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a1/6361848/cedc8237944a/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a1/6361848/a2a006e49fd2/fx3.jpg

相似文献

1
Editorial: Persistent endeavors for the enhancement of dissolution and oral bioavailability.社论：为提高溶出度和口服生物利用度而持续努力。
Acta Pharm Sin B. 2019 Jan;9(1):2-3. doi: 10.1016/j.apsb.2019.01.009. Epub 2019 Jan 29.
2
Precise Dissolution Control and Bioavailability Evaluation for Insoluble Drug Berberine via a Polymeric Particle Prepared Using Supercritical CO₂.通过超临界二氧化碳制备的聚合物颗粒对难溶性药物黄连素进行精确溶出控制和生物利用度评价
Polymers (Basel). 2018 Oct 26;10(11):1198. doi: 10.3390/polym10111198.
3
Effect of magnesium carbonate on the solubility, dissolution and oral bioavailability of fenofibric acid powder as an alkalising solubilizer.碳酸镁对作为碱化增溶剂的非诺贝特酸粉末的溶解度、溶解和口服生物利用度的影响。
Arch Pharm Res. 2016 Apr;39(4):531-538. doi: 10.1007/s12272-015-0701-9. Epub 2016 Mar 18.
4
Oral bioavailability enhancement of β-lapachone, a poorly soluble fast crystallizer, by cocrystal, amorphous solid dispersion, and crystalline solid dispersion.通过共晶、无定形固体分散体和晶体固体分散体提高β-拉帕酮（一种难溶性快速结晶剂）的口服生物利用度。
Eur J Pharm Biopharm. 2018 Mar;124:73-81. doi: 10.1016/j.ejpb.2017.12.016. Epub 2018 Jan 2.
5
Development and Characterization of Venetoclax Nanocrystals for Oral Bioavailability Enhancement.开发和表征 Venetoclax 纳米晶体以提高口服生物利用度。
AAPS PharmSciTech. 2021 Mar 8;22(3):92. doi: 10.1208/s12249-021-01968-1.
6
The Role of Functional Excipients in Solid Oral Dosage Forms to Overcome Poor Drug Dissolution and Bioavailability.功能性辅料在固体口服制剂中对克服药物溶出度差和生物利用度低的作用。
Pharmaceutics. 2020 Apr 25;12(5):393. doi: 10.3390/pharmaceutics12050393.
7
Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.含有冬凌草甲素/羟丙基-β-环糊精包合物的纳米混悬剂，通过改善溶解和渗透性提高口服生物利用度。
AAPS PharmSciTech. 2016 Apr;17(2):400-8. doi: 10.1208/s12249-015-0363-4. Epub 2015 Jul 18.
8
Optimization of Nanostructured Lipid Carriers of Fenofibrate Using a Box-Behnken Design for Oral Bioavailability Enhancement.采用 Box-Behnken 设计优化非诺贝特纳米结构脂质载体以提高口服生物利用度。
Curr Drug Deliv. 2022;19(7):773-787. doi: 10.2174/1567201818666210423110745.
9
Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles.通过形成含表面活性剂的微粒提高难溶性药物的溶出速率和口服吸收。
Int J Pharm. 2006 Jul 6;317(1):61-8. doi: 10.1016/j.ijpharm.2006.03.001. Epub 2006 May 2.
10
Insight into the mechanism behind oral bioavailability-enhancement by nanosuspensions through combined dissolution/permeation studies.通过联合溶解/渗透研究深入了解纳米混悬剂提高口服生物利用度的机制。
Eur J Pharm Sci. 2023 May 1;184:106417. doi: 10.1016/j.ejps.2023.106417. Epub 2023 Mar 2.

引用本文的文献

1
and correlation for lipid-based formulations: Current status and future perspectives.基于脂质的制剂的相关性：现状与未来展望。
Acta Pharm Sin B. 2021 Aug;11(8):2469-2487. doi: 10.1016/j.apsb.2021.03.025. Epub 2021 Mar 21.
2
An update on oral drug delivery intestinal lymphatic transport.口服药物递送的肠道淋巴转运最新进展。
Acta Pharm Sin B. 2021 Aug;11(8):2449-2468. doi: 10.1016/j.apsb.2020.12.022. Epub 2021 Apr 9.
3
The contribution of absorption of integral nanocrystals to enhancement of oral bioavailability of quercetin.

本文引用的文献

1
Exploring the utility of the Chasing Principle: influence of drug-free SNEDDS composition on solubilization of carvedilol, cinnarizine and R3040 in aqueous suspension.探索追踪原理的效用：无药物自乳化药物递送系统（SNEDDS）组合物对卡维地洛、桂利嗪和R3040在水悬浮液中增溶作用的影响
Acta Pharm Sin B. 2019 Jan;9(1):194-201. doi: 10.1016/j.apsb.2018.07.004. Epub 2018 Jul 7.
2
Preparation and characterization of multimodal hybrid organic and inorganic nanocrystals of camptothecin and gold.喜树碱与金的多模态有机-无机杂化纳米晶体的制备与表征
Acta Pharm Sin B. 2019 Jan;9(1):128-134. doi: 10.1016/j.apsb.2018.03.005. Epub 2018 Mar 22.
3
完整纳米晶体的吸收对槲皮素口服生物利用度提高的贡献。
Acta Pharm Sin B. 2021 Apr;11(4):978-988. doi: 10.1016/j.apsb.2021.02.015. Epub 2021 Feb 25.
Development of carrier-free nanocrystals of poorly water-soluble drugs by exploring metastable zone of nucleation.
通过探索成核亚稳区开发难溶性药物的无载体纳米晶体。
Acta Pharm Sin B. 2019 Jan;9(1):118-127. doi: 10.1016/j.apsb.2018.05.004. Epub 2018 Jun 19.
4
Supersaturated polymeric micelles for oral silybin delivery: the role of the Soluplus-PVPVA complex.用于口服水飞蓟宾递送的超饱和聚合物胶束：Soluplus-PVPVA复合物的作用
Acta Pharm Sin B. 2019 Jan;9(1):107-117. doi: 10.1016/j.apsb.2018.09.004. Epub 2018 Sep 10.
5
Drug nanoclusters formed in confined nano-cages of CD-MOF: dramatic enhancement of solubility and bioavailability of azilsartan.在环糊精-金属有机框架的受限纳米笼中形成的药物纳米簇：阿齐沙坦溶解度和生物利用度的显著提高。
Acta Pharm Sin B. 2019 Jan;9(1):97-106. doi: 10.1016/j.apsb.2018.09.003. Epub 2018 Sep 7.
6
Intestinal uptake of barley protein-based nanoparticles for -carotene delivery.基于大麦蛋白的纳米颗粒用于β-胡萝卜素递送的肠道摄取。
Acta Pharm Sin B. 2019 Jan;9(1):87-96. doi: 10.1016/j.apsb.2018.10.002. Epub 2018 Oct 12.
7
Selenium-layered nanoparticles serving for oral delivery of phytomedicines with hypoglycemic activity to synergistically potentiate the antidiabetic effect.用于口服递送具有降血糖活性的植物药以协同增强抗糖尿病作用的硒层状纳米颗粒。
Acta Pharm Sin B. 2019 Jan;9(1):74-86. doi: 10.1016/j.apsb.2018.09.009. Epub 2018 Sep 20.
8
The effects of pH, surfactant, ion concentration, coformer, and molecular arrangement on the solubility behavior of myricetin cocrystals.pH值、表面活性剂、离子浓度、共形成物及分子排列对杨梅素共晶体溶解行为的影响。
Acta Pharm Sin B. 2019 Jan;9(1):59-73. doi: 10.1016/j.apsb.2018.09.008. Epub 2018 Sep 19.
9
Adapting liposomes for oral drug delivery.使脂质体适用于口服药物递送。
Acta Pharm Sin B. 2019 Jan;9(1):36-48. doi: 10.1016/j.apsb.2018.06.005. Epub 2018 Jun 20.
10
Advances in coamorphous drug delivery systems.共无定形药物递送系统的进展
Acta Pharm Sin B. 2019 Jan;9(1):19-35. doi: 10.1016/j.apsb.2018.08.002. Epub 2018 Aug 16.